The latest price target for Calumet (NASDAQ:CLMT) was reported by TD Cowen on November 11, 2024. The analyst firm set a price target for $26.00 expecting CLMT to rise to within 12 months (a possible 19.27% upside). 13 analyst firms have reported ratings in the last year.

The latest analyst rating for Calumet (NASDAQ:CLMT) was provided by TD Cowen, and Calumet maintained their buy rating.

The last upgrade for Calumet Inc happened on August 18, 2022 when Goldman Sachs raised their price target to $23. Goldman Sachs previously had a neutral for Calumet Inc.

There is no last downgrade for Calumet.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Calumet, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Calumet was filed on November 11, 2024 so you should expect the next rating to be made available sometime around November 11, 2025.

While ratings are subjective and will change, the latest Calumet (CLMT) rating was a maintained with a price target of $27.00 to $26.00. The current price Calumet (CLMT) is trading at is $21.80, which is out of the analyst’s predicted range.